Nu Skin Enterprises Q2 2024 Adj. EPS $0.21 Beats $0.17 Estimate, Sales $439.081M Beat $431.871M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nu Skin Enterprises (NYSE:NUS) reported Q2 2024 adjusted EPS of $0.21, beating the $0.17 estimate. Sales were $439.081M, surpassing the $431.871M estimate. However, both EPS and sales decreased significantly compared to the same period last year.
August 08, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Nu Skin Enterprises reported better-than-expected Q2 2024 earnings and sales, but both metrics showed significant declines compared to the same period last year.
While Nu Skin Enterprises beat analyst estimates for both EPS and sales, the significant year-over-year declines in both metrics may temper investor enthusiasm. The mixed results could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100